Infectious Disease Alert – August 1, 2006
August 1, 2006
View Issues
-
Malaria in the United States
The CDC received reports of 1324 patients with malaria in the United States and its territories diagnosed in 2004; 4 patients died. This represented a 3.6% increase in cases from the previous year. US civilians accounted for 58.5% of cases. -
Cubicin® (Daptomycin): Treatment of S. Aureus Bacteremia/Endocarditis
In recent years, S. aureus has been identified as the most common cause of infective endocarditis (IE). Risk factors for S. aureus IE include the presence of indwelling prosthetic devices and intravascular catheters. -
Efavirenz is not Depressing
Alize-anrs was a 48 week randomized controlled trial in which 355 virologically-suppressed, HIV-infected patients receiving PIs were randomized to a continuation regimen containing EFV vs PI. -
Updates By Carol A. Kemper, MD, FACP
As we plunge into the late summer months, thoughts turn again to West Nile Virus. July and August are typically the hottest months for WNV. As of the end of June, 22 states in the continental United States have reported avian, animal, or mosquito WNV infections for the year. -
Pharmacology Watch: The Safety of Long-Acting Beta Agonist Inhalers
Treating Chronic Primary Insomnia; New Breakthrough in Smoking Cessation?; FDA Actions -
Clinical Briefs in Primary Care supplement